{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.4","upperLimit":"12.1","value":"3.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"57"}],"units":"Participants"}],"description":"Toxicity criteria will be assessed and graded according to the National Cancer Institute (NCI) Common Terminology Criteria (CTC) v3.0. Estimated using exact 95% binomial confidence intervals.","dispersionType":"95% Confidence Interval","groups":[{"description":"busulfan: IV busulfan 0.8 mg/kg every 6 hours x 16 doses\n\ncyclophosphamide: IV cyclophosphamide 60 mg/kg over 4 hours x 2 days\n\nautologous hematopoietic stem cell transplantation: infusion of autologous hematopoietic stem cells of at least 2.0 x 106 CD34+ cells/kg on day 0","id":"OG000","title":"Busulfan Treatment"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"At 6 months","title":"Pulmonary Toxicity","type":"SECONDARY","unitOfMeasure":"percentage of participants"}